Rakovina Therapeutics Inc. (TSXV:RKV)
Canada · Delayed Price · Currency is CAD 0.1300
0.00 (0.00%)
May 8, 2026, 10:26 AM EST
Rakovina Therapeutics Market Cap
Rakovina Therapeutics has a market cap or net worth of CAD 2.75 million as of May 8, 2026. Its market cap has decreased by -69.96% in one year.
Market Cap
2.75M
Enterprise Value
4.52M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.13
Market Cap Chart
Since April 1, 2021, Rakovina Therapeutics's market cap has decreased from 14.88M to 2.75M, a decrease of -81.52%. That is a compound annual growth rate of -28.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 2.75M | 30.00% |
| Dec 31, 2025 | 2.11M | -92.08% |
| Dec 31, 2024 | 26.69M | 348.09% |
| Dec 29, 2023 | 5.96M | -52.61% |
| Dec 29, 2022 | 12.57M | -18.16% |
| Dec 31, 2021 | 15.36M | 3.25% |
| Apr 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quest PharmaTech | 6.77M |
| Kane Biotech | 6.36M |
| Aptose Biosciences | 5.64M |
| Restart Life Sciences | 5.64M |
| MYND Life Sciences | 5.22M |
| Doseology Sciences | 3.28M |
| BioVaxys Technology | 3.09M |
| Appili Therapeutics | 1.99M |